Prove safety and effectiveness as well as improvement in near visual acuity performance and increase in near visual acuity. 3 months [clinicaltrials_resource:7c18353ca5f111ecbdf29f463341b014]

Prove safety and effectiveness as well as improvement in near visual acuity performance and increase in near visual acuity. 3 months [clinicaltrials_resource:7c18353ca5f111ecbdf29f463341b014]

Presbyopic patients, slightly hyperopes
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:7c18353ca5f111ecbdf29f463341b014
Intrastromal Correction of Ametropia by a Femtosecond Laser [clinicaltrials:NCT00928122]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Prove safety and effectiveness as well as improvement in near visual acuity performance and increase in near visual acuity. 3 months [clinicaltrials_resource:7c18353ca5f111ecbdf29f463341b014]

Presbyopic patients, slightly hyperopes
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:7c18353ca5f111ecbdf29f463341b014
Bio2RDF identifier
7c18353ca5f111ecbdf29f463341b014
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7c18353ca5f111ecbdf29f463341b014
measure [clinicaltrials_vocabulary:measure]
Prove safety and effectiveness ...... ncrease in near visual acuity.
time frame [clinicaltrials_vocabulary:time-frame]
description
Presbyopic patients, slightly hyperopes
identifier
clinicaltrials_resource:7c18353ca5f111ecbdf29f463341b014
title
Prove safety and effectiveness ...... n near visual acuity. 3 months
@en
inDataset
type
label
Prove safety and effectiveness ...... 8353ca5f111ecbdf29f463341b014]
@en